Indication
Granulosa cell tumor
1 clinical trial
2 products
1 drug
Clinical trial
A Phase II Study of Androgen Receptor (AR) Inhibition by Darolutamide in Combination With Leuprolide Acetate and Exemestane in Recurrent Adult-Type Ovarian Granulosa Cell TumorStatus: , Estimated PCD: 2027-05-31
Product
DarolutamideProduct
ExemestaneDrug
LHRH agonist